You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Attention Score in Context
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Journal for Immunotherapy of Cancer, October 2018
Christophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, Deborah J. Wong, Sebastian Bauer, Rainer Claus, Martin Wermke, Subramanian Hariharan, Anja von Heydebreck, Vijay Kasturi, Vikram Chand, James L. Gulley
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||6||33%|
|Practitioners (doctors, other healthcare professionals)||6||33%|
|Science communicators (journalists, bloggers, editors)||1||6%|
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Bachelor||10||15%|
|Student > Postgraduate||5||7%|
|Student > Doctoral Student||3||4%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||25||37%|
|Biochemistry, Genetics and Molecular Biology||6||9%|
|Pharmacology, Toxicology and Pharmaceutical Science||4||6%|
|Business, Management and Accounting||2||3%|
|Agricultural and Biological Sciences||2||3%|
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2018.
All research outputs
of 24,770,025 outputs
Outputs from Journal for Immunotherapy of Cancer
of 3,352 outputs
Outputs of similar age
of 355,549 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
of 55 outputs
Altmetric has tracked 24,770,025 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,352 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,549 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.